Literature DB >> 11360023

Heavily smoking women who cannot quit in pregnancy: evidence of pharmacokinetic predisposition.

P Selby1, R Hackman, B Kapur, J Klein, G Koren.   

Abstract

SUMMARY: Smoking in pregnancy is associated with a well-characterized increase in perinatal risks. Despite their wish to discontinue smoking, some pregnant women cannot stop. To characterize nicotine and cotinine levels in women who could not quit smoking after the first trimester, the authors recruited 19 white women (age 17-41 years) between 14-23 weeks of gestation who could not quit smoking. They started smoking at ages 11-22 years (mean 14.5) and smoked for 17 +/- 6 years. They had their first cigarettes 5-60 minutes after waking up (mean 12). Nicotine levels were compared with those expected in white patients in the general population, and the cotinine levels per cigarette smoked were compared with the population-based values. Sixteen of the 19 women had nicotine levels substantially lower than those expected. The mean level of serum cotinine produced by one cigarette per day was 19.1 +/- 15.8 ng/mL (range 6.1-67). The expected levels in white patients in the general population are 13 +/- 7.7 ng/mL. The data suggest that pregnant women who cannot quit heavy smoking in the second trimester form a selective group with pharmacokinetic predisposition to a high rate of nicotine metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11360023     DOI: 10.1097/00007691-200106000-00001

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  5 in total

Review 1.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

Review 2.  Nicotine chemistry, metabolism, kinetics and biomarkers.

Authors:  Neal L Benowitz; Janne Hukkanen; Peyton Jacob
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Menstrual phase and depressive symptoms differences in physiological response to nicotine following acute smoking abstinence.

Authors:  Sharon S Allen; Alicia M Allen; Michael Kotlyar; Scott Lunos; Mustafa Al'absi; Dorothy Hatsukami
Journal:  Nicotine Tob Res       Date:  2012-11-15       Impact factor: 4.244

4.  Effects of pregnancy on nicotine self-administration and nicotine pharmacokinetics in rats.

Authors:  Mark G Lesage; Daniel E Keyler; Danielle Burroughs; Paul R Pentel
Journal:  Psychopharmacology (Berl)       Date:  2007-07-07       Impact factor: 4.530

5.  Pharmacological treatment for pregnant women who smoke cigarettes.

Authors:  Bc Chan; G Koren
Journal:  Tob Induc Dis       Date:  2003-09-15       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.